{
  "docId": "019dd923-5ca1-7489-b638-1e7438df5130",
  "docSlug": "69dbae092d5647b8",
  "documentTitle": "Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies",
  "authorId": "LEK",
  "authorName": "LEK",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 8,
  "pageCount": 25,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "data_table",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 14,
  "notes": "NRDL = National Reimbursement Drug List. Data from L.E.K. APAC Hospital Priorities Survey.",
  "elementsJson": [
    "headline_text",
    "bar_chart_vertical",
    "bar_chart_vertical",
    "bar_chart_vertical",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b638-1e7438df5130/8",
  "deckHref": "/decks/019dd923-5ca1-7489-b638-1e7438df5130",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b638-1e7438df5130.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b638-1e7438df5130#slide-8",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "55% NRDL products face some level of prescription restriction",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-c7ca-701b-9ccf-2e951c818af3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.3,
        "x": 0.67,
        "y": 0.42
      },
      "kind": "chart",
      "text": "Prescription restrictions by city tier",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34c5011f-12cb-4518-acbc-f143db4b91c1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.3,
        "x": 0.03,
        "y": 0.42
      },
      "kind": "chart",
      "text": "Prescription restrictions over time (2021-2023)",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "63cd67dd-04ae-4b01-9435-958c099ccc78",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.3,
        "x": 0.35,
        "y": 0.42
      },
      "kind": "chart",
      "text": "Prescription restrictions by hospital tier (L3 vs L2)",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ef431ea1-49e1-44b1-8299-208e2bdf0928",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Percent of NRDL drugs with no prescription limit: 55%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd951-c7ca-701b-9ccf-303d53710718",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.03,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "55% NRDL products face some level of prescription restriction",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1d003aea-ec6a-461a-a6a0-e2c6fd455750",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.35,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "Prescription barrier is largely on par between L3 and L2 hospitals ...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5710d63a-33d5-4e19-9de1-604a627fffe3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.67,
        "y": 0.2
      },
      "kind": "paragraph",
      "text": "... and lower-tiered cities have less of a prescription barrier",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d52f2216-9b07-4da7-97c9-e4749a1dd5b2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: L.E.K. 2021, 2022 and 2023 APAC Hospital Priorities Survey.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "023cf954-2a4e-4aa9-8c05-6c99d09f9bb4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Half of the hospitals continue to face prescription limit for NRDL negotiated drugs, no fundamental change compared to last year",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b478f1b3-1a79-4f13-b840-5c2c6f21b1ce",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [
    {
      "metricRaw": "Percent of NRDL drugs with no prescription limit",
      "numberRaw": "55%",
      "numberKind": "percent",
      "actionTitle": "Half of the hospitals continue to face prescription limit for NRDL negotiated drugs, no fundamental change compared to last year",
      "calloutText": "55% NRDL products face some level of prescription restriction",
      "numberScale": null,
      "numberValue": 55,
      "metricFamily": "other",
      "numberCurrency": null
    }
  ],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 13,
      "from": 4,
      "beatId": "6255b8e4-cee9-45a2-b2ca-d853f7565f1a",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "The deck provides various data tables and industry trends to support the analysis.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 21,
      "from": 4,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "14774306-9477-4114-91ee-c8939ad08575",
      "evidence": "The deck presents various data tables and industry trends to support the analysis and provide insights on hospital priorities and digital health solutions.",
      "position": 1,
      "objective": "How can pharmas support hospitals to achieve their goals?",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}